BNTC icon

Benitec Biopharma
BNTC

Overview Fund Trends Analyst Outlook Journalist POV

17 hedge funds and large institutions have $5.57M invested in Benitec Biopharma in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$752
2
+$4

Top Sellers

1
-$47K
2
-$45.3K
3
-$16.9K
4
Two Sigma Investments
Two Sigma Investments
New York
-$5.61K
5
CF
Cantor Fitzgerald
New York
-$5.26K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.12M
2
$2.38M
3
$17.8K
4
$13K
5
$11.5K
6
$9.21K
7
$5.11K
8
$3.14K
9
$3.09K
10
$2.82K
11
$1.78K
12
$752
13
$358
14
$91
15
$82
16
$48
17
–
18
–
19
–
20
–
21
–